These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34918882)

  • 1. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
    Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
    Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
    Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
    Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the relationship of lymphangiogenesis markers with disease pathogenesis in patients with Behçet's uveitis.
    Özgürtaş T; Yücel Ç; Sertoğlu E; Hayran Y; Çolak S; Tekgöz E; Omma A; Durukan AH
    Acta Clin Belg; 2022 Apr; 77(2):387-395. PubMed ID: 33629934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor gene polymorphisms in Behçet's disease.
    Salvarani C; Boiardi L; Casali B; Olivieri I; Cantini F; Salvi F; Malatesta R; La Corte R; Triolo G; Ferrante A; Filippini D; Paolazzi G; Sarzi-Puttini P; Nicoli D; Farnetti E; Chen Q; Pulsatelli L
    J Rheumatol; 2004 Sep; 31(9):1785-9. PubMed ID: 15338501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease.
    Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K
    Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients.
    Harmanci K; Akan OY; Pirildar T; Ortan P; Ulman C
    Dis Markers; 2018; 2018():2649392. PubMed ID: 30420902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population.
    Shahriyari E; Bonyadi M; Jabbarpoor Bonyadi MH; Soheilian M; Yaseri M; Ebrahimiadib N
    Curr Eye Res; 2019 Feb; 44(2):200-205. PubMed ID: 30289285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
    Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
    Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
    Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
    Robak E; Sysa-Jedrzejewska A; Robak T
    Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
    Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
    Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease.
    Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM
    Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
    Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
    Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs' uveitis syndrome and Behçet's uveitis.
    Simsek M; Cakar Ozdal P; Akbiyik F; Citirik M; Berker N; Ozdamar Erol Y; Yilmazbas P
    Int Ophthalmol; 2019 Nov; 39(11):2629-2636. PubMed ID: 31065903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
    Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
    J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.
    Kwinta P; Bik-Multanowski M; Mitkowska Z; Tomasik T; Pietrzyk JJ
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.